361 related articles for article (PubMed ID: 17014674)
21. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
22. The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses.
Nagel H; Maag S; Tassis A; Nestlé FO; Greber UF; Hemmi S
Gene Ther; 2003 Sep; 10(19):1643-53. PubMed ID: 12923563
[TBL] [Abstract][Full Text] [Related]
23. Characterization of infectivity of knob-modified adenoviral vectors in glioma.
Paul CP; Everts M; Glasgow JN; Dent P; Fisher PB; Ulasov IV; Lesniak MS; Stoff-Khalili MA; Roth JC; Preuss MA; Dirven CM; Lamfers ML; Siegal GP; Zhu ZB; Curiel DT
Cancer Biol Ther; 2008 May; 7(5):786-93. PubMed ID: 18756624
[TBL] [Abstract][Full Text] [Related]
24. A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.
Ranki T; Kanerva A; Ristimäki A; Hakkarainen T; Särkioja M; Kangasniemi L; Raki M; Laakkonen P; Goodison S; Hemminki A
Gene Ther; 2007 Jan; 14(1):58-67. PubMed ID: 16900223
[TBL] [Abstract][Full Text] [Related]
25. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
[TBL] [Abstract][Full Text] [Related]
26. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
27. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.
Koizumi N; Mizuguchi H; Utoguchi N; Watanabe Y; Hayakawa T
J Gene Med; 2003 Apr; 5(4):267-76. PubMed ID: 12692861
[TBL] [Abstract][Full Text] [Related]
28. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.
Kasono K; Blackwell JL; Douglas JT; Dmitriev I; Strong TV; Reynolds P; Kropf DA; Carroll WR; Peters GE; Bucy RP; Curiel DT; Krasnykh V
Clin Cancer Res; 1999 Sep; 5(9):2571-9. PubMed ID: 10499635
[TBL] [Abstract][Full Text] [Related]
29. Assessment of optimal virus-mediated growth factor gene delivery for human cutaneous wound healing enhancement.
Escámez MJ; Carretero M; García M; Martínez-Santamaría L; Mirones I; Duarte B; Holguín A; García E; García V; Meana A; Jorcano JL; Larcher F; Del Río M
J Invest Dermatol; 2008 Jun; 128(6):1565-75. PubMed ID: 18185534
[TBL] [Abstract][Full Text] [Related]
30. Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.
Borovjagin AV; Krendelchtchikov A; Ramesh N; Yu DC; Douglas JT; Curiel DT
Cancer Gene Ther; 2005 May; 12(5):475-86. PubMed ID: 15706356
[TBL] [Abstract][Full Text] [Related]
31. An adenoviral vector containing an arg-gly-asp (RGD) motif in the fiber knob enhances protein product levels from transgenes refractory to expression.
Campbell M; Qu S; Wells S; Sugandha H; Jensen RA
Cancer Gene Ther; 2003 Jul; 10(7):559-70. PubMed ID: 12833136
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma.
Hoffmann D; Heim A; Nettelbeck DM; Steinstraesser L; Wildner O
Hum Gene Ther; 2007 Jan; 18(1):51-62. PubMed ID: 17184155
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.
Smith TA; Idamakanti N; Rollence ML; Marshall-Neff J; Kim J; Mulgrew K; Nemerow GR; Kaleko M; Stevenson SC
Hum Gene Ther; 2003 May; 14(8):777-87. PubMed ID: 12804140
[TBL] [Abstract][Full Text] [Related]
35. Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5/3 chimerism.
Volk AL; Rivera AA; Kanerva A; Bauerschmitz G; Dmitriev I; Nettelbeck DM; Curiel DT
Cancer Biol Ther; 2003; 2(5):511-5. PubMed ID: 14614316
[TBL] [Abstract][Full Text] [Related]
36. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.
Grill J; Van Beusechem VW; Van Der Valk P; Dirven CM; Leonhart A; Pherai DS; Haisma HJ; Pinedo HM; Curiel DT; Gerritsen WR
Clin Cancer Res; 2001 Mar; 7(3):641-50. PubMed ID: 11297260
[TBL] [Abstract][Full Text] [Related]
37. Enhancing Adenoviral-Mediated Gene Transfer and Expression to Endometrial Cells.
Othman ER; Curiel DT; Hussein M; Abdelaal II; Fetih AN; Al-Hendy A
Reprod Sci; 2016 Aug; 23(8):1109-15. PubMed ID: 26865542
[TBL] [Abstract][Full Text] [Related]
38. A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis.
Bakker AC; Van de Loo FA; Joosten LA; Bennink MB; Arntz OJ; Dmitriev IP; Kashentsera EA; Curiel DT; van den Berg WB
Gene Ther; 2001 Dec; 8(23):1785-93. PubMed ID: 11803398
[TBL] [Abstract][Full Text] [Related]
39. Adenoviral gene delivery to primary human cutaneous cells and burn wounds.
Hirsch T; von Peter S; Dubin G; Mittler D; Jacobsen F; Lehnhardt M; Eriksson E; Steinau HU; Steinstraesser L
Mol Med; 2006; 12(9-10):199-207. PubMed ID: 17225867
[TBL] [Abstract][Full Text] [Related]
40. Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus.
Tyler MA; Ulasov IV; Borovjagin A; Sonabend AM; Khramtsov A; Han Y; Dent P; Fisher PB; Curiel DT; Lesniak MS
Mol Cancer Ther; 2006 Sep; 5(9):2408-16. PubMed ID: 16985075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
